Skip to content

13F-HR filed by venBio Partners LLC

venBio Partners LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 9 holding rows worth $555,056,000.

Accession
0001567619-22-004453
Filed
2022-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 9 entries on the cover page, a total value of $555,056,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $555,056,000 with VALUE read as thousands by filing date, 13F file number 028-19529. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK9,699,925$208,451,000thousands by filing date
HARMONY BIOSCIENCES HLDGS IN413197104COM2,740,411$116,851,000thousands by filing date
Ventyx Biosciences Inc92332V107Common Stock5,011,536$99,529,000thousands by filing date
AKERO THERAPEUTICS INC00973Y108COM2,171,664$45,931,000thousands by filing date
PHARVARIS NVN69605108COMMON STOCK2,303,310$33,145,000thousands by filing date
IMPEL PHARMACEUTICALS INC45258K109CMN2,759,791$23,817,000thousands by filing date
ELEVATION ONCOLOGY INC COM28623U101Stock2,608,167$15,701,000thousands by filing date
CHECKMATE PHARMACEUTICALS IN162818108COM3,673,374$10,543,000thousands by filing date
VERONA PHARMA PLC925050106SPONSORED ADS161,897$1,088,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-22-004453this filing2022-02-14acceptance time not in the bulk data set